Giampietro, Antonella
 Distribuzione geografica
Continente #
EU - Europa 2.250
NA - Nord America 2.176
AS - Asia 345
AF - Africa 14
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 4.799
Nazione #
US - Stati Uniti d'America 2.167
DE - Germania 970
SE - Svezia 393
IT - Italia 265
CN - Cina 241
UA - Ucraina 176
IE - Irlanda 115
FR - Francia 98
GB - Regno Unito 63
PL - Polonia 58
FI - Finlandia 47
IN - India 40
BE - Belgio 22
NL - Olanda 15
IR - Iran 14
JP - Giappone 13
TR - Turchia 10
CI - Costa d'Avorio 9
RU - Federazione Russa 9
SG - Singapore 9
CA - Canada 8
HK - Hong Kong 8
VN - Vietnam 6
CO - Colombia 4
BG - Bulgaria 3
EU - Europa 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BR - Brasile 2
ES - Italia 2
GH - Ghana 2
MD - Moldavia 2
PE - Perù 2
AU - Australia 1
BD - Bangladesh 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HU - Ungheria 1
IQ - Iraq 1
KR - Corea 1
KW - Kuwait 1
LI - Liechtenstein 1
MA - Marocco 1
NG - Nigeria 1
PT - Portogallo 1
SC - Seychelles 1
Totale 4.799
Città #
Chandler 582
Ashburn 128
San Mateo 108
Dublin 107
New York 105
Ann Arbor 82
Jacksonville 72
Fairfield 68
Wilmington 68
Marseille 61
Nürnberg 55
Boston 53
Warsaw 53
Rome 49
Milan 48
Nanjing 47
Bremen 44
Cattolica 40
Princeton 40
Seattle 36
Dearborn 34
Houston 31
Redwood City 31
Woodbridge 29
Nanchang 24
Cambridge 23
Los Angeles 22
Beijing 21
Brussels 21
Lawrence 21
Hangzhou 20
Mountain View 20
Shanghai 20
Zhengzhou 19
Boardman 17
Helsinki 17
University Park 17
Munich 15
Fremont 14
Shenyang 14
Guangzhou 12
Norwalk 12
Augusta 11
Leawood 11
Hebei 10
Izmir 10
Kunming 10
Abidjan 9
Chicago 9
Kish 9
Redmond 9
Changsha 8
Hong Kong 8
Lancaster 8
Brescia 7
Piacenza 7
Pune 7
Washington 7
Andover 6
Canterbury 6
Jiaxing 6
Singapore 6
Tianjin 6
West Jordan 6
Hanoi 5
Menlo Park 5
Mumbai 5
Renton 5
Amsterdam 4
Cornaredo 4
Monmouth Junction 4
Sakaemachi 4
Utrecht 4
Ardabil 3
Bari 3
Campobasso 3
Dalmine 3
Fuzhou 3
Gunzenhausen 3
Indiana 3
Jinan 3
Mercato San Severino 3
Ningbo 3
Paris 3
Sacramento 3
Toronto 3
Ypsilanti 3
Accra 2
Barbarano Vicentino 2
Bergamo 2
Berlin 2
Bogen 2
Bogotá 2
Buffalo Junction 2
Cerveteri 2
Cesa 2
Chisinau 2
Fort Worth 2
Frankfurt am Main 2
Haikou 2
Totale 2.584
Nome #
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 228
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 224
Double pituitary adenomas 185
Male fertility and reduction in semen parameters: A single tertiary-care center experience 147
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 140
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 133
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 133
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 128
Role of a mini-invasive approach in the diagnosis and treatment of tubo-peritoneal infertility as an altenative to IVF [Il ruolo di un approccio chirurgico mini-invasivo nella diagnosi e trattamento della sterilità tubo-peritoneale in alternativa alla FIVET] 128
NOVEL BIOMARKERS OF ANDROGEN DEFICIENCY FROM SEMINAL PLASMA PROFILING USING HIGH-RESOLUTION MASS SPECTROMETRY. 122
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 119
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 115
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study 113
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 99
Isolated growth hormone deficiency: clinical entity? 98
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 98
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 97
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 95
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 94
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 91
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 89
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 88
Fertility and hypopituitarism 87
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 86
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 86
GH receptor isoforms and skeletal fragility in acromegaly 80
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 79
The Changing Clinical Spectrum of Hypophysitis 79
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 72
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 69
Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry 63
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 61
Vertebral fractures in patients with acromegaly: a 3-year prospective study 60
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 59
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 58
Quantitative Analysis of the Seminal Plasma Proteome in Secondary Hypogonadism 56
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 55
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 53
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 52
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 49
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 48
Solitary Metastatic Melanoma of the Pituitary Gland: Report of Two Cases and Literature Review 47
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 46
Empty sella syndrome: Multiple endocrine disorders. 45
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 45
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 45
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 44
Understanding the effect of acromegaly on the human skeleton. 44
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 43
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 42
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 40
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 40
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 40
Hypothalamitis and pituitary atrophy 38
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 37
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 36
Acromegaly can be cured by first-line pasireotide treatment? 35
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 35
Acromegaly in the elderly patients 32
Bone safety of dual-release hydrocortisone in patients with hypopituitarism. 31
Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study 29
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 24
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 13
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 10
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 6
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 3
Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study 3
Colon Cancer Presenting as Pituitary Mass and Hypopituitarism: Recognition and Multidisciplinary Approach of a Rare Case 3
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 3
Second line treatment of acromegaly: Pasireotide or Pegvisomant? 2
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 2
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 1
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 1
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 1
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 1
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 1
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 1
De-escalation treatment with pasireotide for acromegaly: a long-term experience 1
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 1
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 1
Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly 1
Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma 1
Totale 4.890
Categoria #
all - tutte 16.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019132 0 0 0 0 0 0 0 0 0 51 40 41
2019/2020682 112 41 50 60 43 53 108 35 35 46 67 32
2020/2021419 20 42 11 42 50 27 47 9 43 55 68 5
2021/2022617 30 33 7 47 74 27 10 112 28 26 85 138
2022/20231.516 173 207 123 252 80 211 89 127 157 13 53 31
2023/2024514 32 160 17 32 31 142 35 8 28 29 0 0
Totale 4.890